PAD

R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO

Retrieved on: 
星期四, 五月 9, 2024

The company also announced that veteran medical device executive Christopher M. Owens will serve as its new President and Chief Executive Officer.

Key Points: 
  • The company also announced that veteran medical device executive Christopher M. Owens will serve as its new President and Chief Executive Officer.
  • The Series B financing was led by affiliates of Deerfield Management with participation from existing shareholders including 415 Capital and a strategic investor.
  • R3 Vascular will use the proceeds to support the ELITE FDA IDE pivotal trial of its best-in-class bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD.
  • Commenting on the financing and the appointment of Mr. Owens, Jack Springer, Executive Chairman of R3 Vascular said, “On behalf of the R3 Vascular Board of Directors, we are very pleased to complete this exciting Series B financing and welcome Chris Owens as President and CEO.

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

Retrieved on: 
星期三, 五月 8, 2024

“PAD affects over 230 million people globally, presenting a significantly underrecognized risk of CAD,” said Dr. Frank Arko, Chief of Vascular and Endovascular Surgery at Atrium Health Sanger Heart & Vascular Institute.

Key Points: 
  • “PAD affects over 230 million people globally, presenting a significantly underrecognized risk of CAD,” said Dr. Frank Arko, Chief of Vascular and Endovascular Surgery at Atrium Health Sanger Heart & Vascular Institute.
  • “In an additional study looking at a similar patient population, we studied 170 high-risk PAD patients, where we utilized systematic FFRCT testing.
  • Remarkably, 70 percent of these patients had hemodynamically significant CAD, which is a major risk factor for cardiac complications.
  • This publication showcases the company’s continued commitment to revolutionizing patient care with innovative and scientifically validated technologies.

authID Inc. Partners with IDMWORKS to Expand Reach of Its Biometric Identity Platform

Retrieved on: 
星期三, 五月 8, 2024

DENVER, May 08, 2024 (GLOBE NEWSWIRE) --  authID.ai [Nasdaq: AUID], a leading provider of innovative biometric identity verification and authentication solutions, and IDMWORKS, an industry-leading identity and access management (IAM) solutions provider, today announced they have signed a reseller agreement to expand the availability of authID’s biometric capabilities to IDMWORKS workforce and customer identity clients across North America. Under the agreement, IDMWORKS, a valued IAM expert since 2004, will resell and integrate authID’s biometric identity solutions with leading financial, healthcare, and supply chain businesses to deliver strong identity assurance that stops unauthorized access and business disruption caused by phishing attacks, deepfakes, and compromised credentials.

Key Points: 
  • “We greatly value our new partnership with IDMWORKS, an industry-leading IAM solutions provider, and are excited to increase the breadth of our opportunities and expand the reach of our next-gen authentication solutions into the verticals they service,”  said Rhon Daguro, CEO of authID.
  • To help client organizations solve these complex challenges and enable secure interactions with their customers, partners, and employees, IDMWORKS will leverage authID’s highly secure identity verification and biometric multi-factor authentication, that provides market-leading 700 milliseconds biometric processing and an easy, frictionless user experience.
  • “authID’s trusted biometric solutions have proven to be superior in defending against today’s adversarial AI-driven phishing scams and cyberattacks across both customer and workforce identity platforms,” said Paul Bedi, CEO of IDMWORKS.
  • Continued Daguro, “authID’s biometric identity platform delivers speed and accuracy, processing captured images, and identifying users as legitimate or fraudulent, all within a market-leading 700 milliseconds.

Cagent Vascular appoints Chairman Brian Walsh to expanded role as Chief Executive Officer

Retrieved on: 
星期二, 五月 7, 2024

Cagent Vascular announced today that Brian Walsh has been named Chief Executive Officer by the Cagent Vascular Board of Directors.

Key Points: 
  • Cagent Vascular announced today that Brian Walsh has been named Chief Executive Officer by the Cagent Vascular Board of Directors.
  • Mr. Walsh previously served as Head of Carl Zeiss Meditech Cataract Technology from 2018 until 2024.
  • Brian Walsh brings over 25 years of medical device and health care industry experience in Marketing, Sales, and Executive Leadership which positions him as the ideal candidate to drive the market adoption of Cagent Vascular’ s flagship product, Serranator.
  • “Cagent Vascular is an exceptional company with a disruptive technology platform and a highly talented team,” Mr. Walsh said.

Tax Tip - Looking for the fastest and easiest way to view and manage your business taxes online? Use our digital services!

Retrieved on: 
星期三, 五月 8, 2024

The GST/HST calculator is used to find out the amount of tax that applies to sales in Canada.

Key Points: 
  • The GST/HST calculator is used to find out the amount of tax that applies to sales in Canada.
  • In five simple steps, you can calculate the GST/HST rates as well as the total amount of a sale before and after tax.
  • In addition, the GST/HST provincial rates table gives an overview of the GST/HST rates across Canada starting from 2008.
  • This page outlines options to make it easier to file a tax return and get your benefits and credits.

Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee

Retrieved on: 
星期一, 四月 29, 2024

The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.

Key Points: 
  • The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
  • Until today, there were no stents or drug-coated balloons approved for use below the knee in the U.S.
  • The Esprit BTK System is a first-of-its-kind dissolvable stent and is comprised of material similar to dissolving sutures.
  • That's why we're revolutionizing treatments with resorbable scaffold technology below the knee," said Julie Tyler, senior vice president of Abbott's vascular business.

authID Selected by National Notarial Centralized Verification System For Secure Biometric Identity Assurance

Retrieved on: 
星期四, 四月 18, 2024

Denver, April 18, 2024 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of secure, biometric identity verification and authentication solutions and National Notarial Centralized Verification System (NNCVS), today announced that NNCVS will deploy authID’s biometric identity life-cycle platform to provide real-time identity assurance to the company’s innovative online technology platform for commissioned notaries and their clients. With increasing frequency of social engineering fraud, deepfakes, and ransomware attacks, NNCVS selected authID’s for its ability to stop fraud, detect deepfakes, and combat adversarial generative AI, all while delivering a fast, seamless user authentication experience. 

Key Points: 
  • Denver, April 18, 2024 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of secure, biometric identity verification and authentication solutions and National Notarial Centralized Verification System (NNCVS), today announced that NNCVS will deploy authID’s biometric identity life-cycle platform to provide real-time identity assurance to the company’s innovative online technology platform for commissioned notaries and their clients.
  • Providing the first-ever nationwide verification system for notaries, the NNCVS platform is transforming the current ‘localized and in-person’ notary industry into a robust national online service that makes notarization faster, more efficient, and more secure.
  • “authID’s next-gen biometric identity platform is paramount to our mission to revolutionize the notary industry by providing strong identity assurance that prevents fraudulent account openings and phishing-related account takeovers, while delivering the convenience today’s online users expect,” said Stefan Perez Tejera, CEO of National Notarial Centralized Verification System.
  • “We are excited to help National Notarial Centralized Verification System revolutionize the notary industry by delivering the highest levels of identity trust with market leading speed, precision and accuracy, while deepening user trust with frictionless identity experiences.”

Nametag Launches Self-Service Account Recovery Solution That Stops AI-Generated Deepfake Attacks

Retrieved on: 
星期一, 三月 25, 2024

SEATTLE, March 25, 2024 (GLOBE NEWSWIRE) -- Nametag, the identity verification platform for helpdesks, today announced the launch of Nametag Autopilot, the only self-service account recovery solution that prevents AI-generated deepfake attacks. Account recovery requests represent a significant single point of failure in IT security, susceptible to ransomware, data breaches, and injection attacks, including the use of AI deepfakes. Nametag Autopilot prevents social engineering and impersonation attacks while saving organizations millions by deflecting expensive password and multifactor authentication (MFA) resets to self-service.

Key Points: 
  • HubSpot taps Nametag to secure helpdesk operations, inspire trust, and improve user experience
    SEATTLE, March 25, 2024 (GLOBE NEWSWIRE) -- Nametag , the identity verification platform for helpdesks, today announced the launch of Nametag Autopilot , the only self-service account recovery solution that prevents AI-generated deepfake attacks.
  • So when a helpdesk agent grants an account reset, they inadvertently blow the door wide open to data breaches and ransomware attacks.
  • In this way, Nametag stops account takeovers (ATOs) and data breaches by verifying users at critical moments like account recoveries, MFA resets, and high-risk transactions.
  • “I am excited about our new partnership with Nametag for its account recovery solution as it promises to elevate our customer experience to new heights.

Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update

Retrieved on: 
星期五, 三月 22, 2024

DURHAM, N.C., March 22, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced financial results for the fourth quarter and year ended December 31, 2023 and highlighted recent corporate accomplishments in advancing the investigational Human Acellular Vessel (HAV) closer to planned U.S. market launch.

Key Points: 
  • There was no revenue for either the fourth quarter of 2023 or the fourth quarter of 2022, and there was no revenue for the year ended December 31, 2023.
  • Research and development expenses were $20.2 million for the fourth quarter of 2023, compared to $15.0 million for the fourth quarter of 2022, and were $76.6 million for the year ended December 31, 2023, compared to $63.3 million for the year ended December 31, 2022.
  • General and administrative expenses were $6.0 million for the fourth quarter of 2023, compared to $5.8 million for the fourth quarter of 2022, and were $23.5 million for the year ended December 31, 2023, compared to $22.9 million for the year ended December 31, 2022.
  • The 2023 increases in net loss resulted from the non-cash remeasurement of the contingent earnout liability, and operating expense increases, described above.

authID and Verified Inc. Partner to Launch 1-Click Identity Verification

Retrieved on: 
星期三, 三月 13, 2024

Denver, March 13, 2024 (GLOBE NEWSWIRE) --  authID Inc. (Nasdaq: AUID), a leading provider of secure biometric identity verification and authentication solutions, and Verified Inc., a pioneering digital identity network that powers 1-Click onboarding experiences, today announced a partnership to launch 1-Click identity verification. Through the convergence of authID’s patented biometric identity platform and Verified Inc.’s identity wallet, the companies jointly provide instant, secure, and automated customer onboarding with the highest identity assurance.

Key Points: 
  • Combining best-in-class identity fraud and account takeover prevention with a secure, frictionless customer onboarding experience
    Denver, March 13, 2024 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of secure biometric identity verification and authentication solutions, and Verified Inc. , a pioneering digital identity network that powers 1-Click onboarding experiences, today announced a partnership to launch 1-Click identity verification.
  • Through the convergence of authID’s patented biometric identity platform and Verified Inc.’s identity wallet, the companies jointly provide instant, secure, and automated customer onboarding with the highest identity assurance.
  • The abundance of stolen personal data and the acceleration of AI-driven phishing attacks and account takeovers are driving increasing demand for highly certain identity verification and life-cycle multi-factor authentication.
  • Needing a trusted technology partner to deliver strong identity verification coupled with a seamless user authentication experience, Verified Inc. partnered with authID for its market-leading speed, accuracy and precision.